| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00018 | 1 |